Filter
1136
Text search:
drug-resistant
TB
Featured
122
307
Language
Document type
734
128
120
37
37
36
23
15
2
1
1
1
1
Countries / Regions
54
52
46
41
37
20
20
20
20
20
19
19
18
18
15
15
14
13
13
13
12
12
11
11
11
10
9
7
6
6
6
6
5
5
5
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
455
100
30
15
14
10
9
Toolboxes
547
85
84
17
17
16
15
13
12
11
10
10
9
3
3
3
3
2
2
2
2
1
1
In 2019, the Global Fund’s 6th Replenishment raised more than $USD14 billion to fight HIV, Tuberculosis and Malaria. Just two years later, the world has changed significantly. Put simply: COVID-19 devastated prevention and treatment programs. For the first time since the Global Fund’s founding,
...
Rappart sur les populations clés.
TB policies in 24 Countries
A survey of prevention, testing and treatment policies and practices
Лечение туберкулеза в 24 странах
Исследование диагностической и клинической пра
...
Accessed December 2017
Key populations brief.
Technical information note. Digital Adherence Technologies (DATs) such as the smart medication container
kit can help to support people affected by TB with their treatment in a modern
and ef-fective way. These technologies are able to deliver remi
...
Informe sobre poblaciones clave.
Key populations brief.
Краткое руководство
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Исследование этого года основано на предыдущем отчете. В нем отслеживается утверждение последних стратегий, руководств и методов в пяти сферах: диагностика и иссл
...
Key Populations Brief
Accessed November 2017
Advocacy report March 2011
303100 03/2011 E 1,000
For Children and their Families
October 2015
A resource for the continued implementation of the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively
Drug-Resistant Tuberculosis in the WHO European Region 2011-2015
Please
...
